Cambridge Associates Portfolio holdings
Top Buys
| 1 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$89.3M |
| 2 |
SPDR Gold Trust
GLD
|
+$38.8M |
| 3 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$32.7M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$12.7M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$11.5M |
Top Sells
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$80.2M |
| 2 |
WisdomTree Europe Hedged Equity Fund
HEDJ
|
+$25.3M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.55M |
| 4 |
Vanguard Total World Stock ETF
VT
|
+$5.2M |
| 5 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$4.01M |
Sector Composition
| 1 | Real Estate | 1.8% |
| 2 | Industrials | 0.64% |
Similar funds
Cambridge Associates's Q1 2017 Portfolio in Review
As of Q1 2017, Cambridge Associates held 35 positions worth $597M, up 26% from $476M the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Cambridge Associates deployed $106M of net new capital in Q1 2017, opening 5 new positions and adding to 12 existing holdings. Its largest new stake was Vanguard Short-Term Corporate Bond ETF: 1,122,301 shares worth $89.5M.
By sector, the portfolio is most concentrated in Real Estate at 1.8% of assets, down from 2.7% a quarter earlier, followed by Industrials.
On the sell side, the largest reduction was Vanguard Intermediate-Term Corporate Bond ETF, an estimated $80.2M trimmed.
- Cambridge Associates's largest Q1 2017 buy was Vanguard Short-Term Corporate Bond ETF: 1,122,301 shares worth $89.5M.
- Cambridge Associates added most to SPDR Gold Trust in Q1 2017, an estimated $38.8M increase.
- Cambridge Associates's biggest Q1 2017 reduction was Vanguard Intermediate-Term Corporate Bond ETF, cutting an estimated $80.2M.
- Cambridge Associates fully exited WisdomTree Europe Hedged Equity Fund in Q1 2017, selling an estimated $25.3M.
- Cambridge Associates's ten largest holdings make up 76% of its $597M portfolio in Q1 2017.
- Cambridge Associates opened 5 new positions and closed 3 in Q1 2017.
- Cambridge Associates's portfolio value rose 26% quarter-over-quarter to $597M.
Based on Cambridge Associates's 13F filing for Q1 2017, filed 12 May 2017.